https://www.pro.novartis.com/ua-uk/ 2026-03-30T09:40:08+00:00 daily 1.0 https://www.pro.novartis.com/ua-uk/skafo-sekukinumab-psoriatychnyy-artryt-efektyvnist-1 2025-04-12T12:04:00+00:00 hourly 0.5 https://www.pro.novartis.com/ua-uk/skafo-sekukinumab-psoriatychnyy-artryt-efektyvnist-2 2025-04-12T12:05:28+00:00 hourly 0.5 https://www.pro.novartis.com/ua-uk/skafo-sekukinumab-psoriatychnyy-artryt-efektyvnist-3 2025-04-12T12:06:17+00:00 hourly 0.5 https://www.pro.novartis.com/ua-uk/node/1 2026-03-30T09:40:08+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-areas-1 2025-04-17T12:03:54+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/paywall 2025-04-15T16:09:57+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/resources 2026-04-02T19:35:37+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/privacy 2025-09-17T06:37:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/terms 2025-09-11T15:12:04+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/accessibility 2025-04-10T17:09:35+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/contact 2025-04-22T13:16:11+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-area/rheumatology 2025-04-23T10:43:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-area/dermatology 2025-06-05T12:23:59+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-area/oncology 2025-10-16T10:52:41+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-area/neuroscience 2025-04-15T07:04:55+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/therapy-area/cardio-metabolic 2025-09-24T20:23:35+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology 2025-04-14T09:26:27+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/neurology 2025-04-10T07:46:34+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/dermatology 2025-04-17T11:58:01+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic 2025-09-19T12:49:43+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/not-available 2025-04-23T09:46:39+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/cookie 2025-06-24T12:50:36+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events 2025-11-08T19:57:38+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/dermatology 2026-03-30T08:14:17+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/rheumatology 2026-03-30T08:16:31+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/cardio-metabolic 2025-11-08T20:00:13+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/oncology 2025-11-08T20:00:19+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/neurology 2025-11-08T20:43:28+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/events/gematology 2025-11-08T20:00:15+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/resources/cpinalna-myazova-atrofiya 2026-03-30T09:27:24+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali 2025-10-27T15:13:08+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/dermatology/scapho/pso/efficacy 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali/abc/premenopausal-women 2025-10-18T08:14:27+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/dermatology/scapho/pso/security 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/dermatology/scapho/pso/mechanism 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/dermatology/scapho/pso/dosing 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/oncology/kisqali/abc/postmenopausal-women 2025-10-18T08:14:24+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali/abc/efficacy 2025-10-16T21:15:23+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali/abc/method-doses 2025-10-17T11:29:55+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/neurology/bonspri/security 2025-10-05T07:32:48+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/neurology/bonspri/dosing 2025-10-05T07:32:26+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/neurology/bonspri/efficacy 2025-10-05T07:31:58+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali/abc/adverse-reactions 2025-10-17T11:31:17+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/kisqali/abc/action-mechanism 2025-10-05T07:29:25+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/axial-spondyloarthritis 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis/efficacy 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis/safety 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis/action-mechanism 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis/dosing 2025-09-25T15:54:44+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/axial-spondyloarthritis/efficacy 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/axial-spondyloarthritis/safety 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/axial-spondyloarthritis/action-mechanism 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/axial-spondyloarthritis/dosing 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/additional-info 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/why 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/open 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/study-patients 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/important-results 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/efficiency 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/safeties 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/significances 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/additional-info-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/why-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/open-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/study-patients-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/important-results-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/efficiency-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/safety-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/significance-correction 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/additional-info-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/why-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/open-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/study-patients-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/important-results-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/efficiency-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/safety-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/sybrava/significance-correction-risk 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/patients-safety 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/chi-mozhu-ya-priznachati-yuperio-paciyentam-z-fvlsh-40 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yaku-informaciyu-pro-zastosuvannya-yuperio-pid-chas-likuvannya-sn-mistyat-rekomendaciyi-ahaacchfsa-2022-roku 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/chomu-meni-slid-rozglyadati-preparat-yuperio-navit-yaksho-paciyent-demonstruye-stabilnij-stan-otrimuyuchi-likuvannya-za-potochnim-planom 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/chi-mozhna-rozpochati-zastosuvannya-preparatu-yuperio-v-umovah-stacionaru-hto-same-mozhe-ce-zrobiti 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/chim-yuperio-vidriznyayetsya-vid-inshih-ingibitoriv-ras 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yakoyu-bula-efektivnist-preparatu-yuperio-v-porivnyanni-z-enalaprilom-u-doslidzhenni-paradigm-hf-vrahovuyuchi-arr-i-nnt-u-paciyentiv-iz-sn-zi-znizhenoyu-fv 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yakoyu-bula-efektivnist-yuperio-v-porivnyanni-z-valsartanom-u-doslidzhenni-paragon-hf-u-paciyentiv-z-fvlsh-60 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yak-yuperio-vplivaye-na-rivni-bnp-i-nt-probnp 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yakim-buv-efekt-yuperio-v-porivnyanni-z-valsartanom-u-doslidzhenni-paraglide-hf-u-stabilizovanih-paciyentiv-iz-sn-z-pomirno-znizhenoyu-ta-zi-zberezhenoyu-fv-pislya-podiyi-povyazanoyi-z-negativnoyu-dinamikoyu-sn 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yak-yuperio-vplivav-na-pokazniki-biomarkeriv-i-remodelyuvannya-sercya-pokazniki-strukturi-ta-funkciyi-sercya-u-paciyentiv-iz-sn-zi-znizhenoyu-fv 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yaki-ye-dani-pro-zastosuvannya-yuperio-v-realnij-praktici 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/efficacy/yak-yuperio-vplivaye-na-povtornu-gospitalizaciyu-z-privodu-sn-u-paciyentiv-iz-sn-zi-znizhenoyu-fv 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-slid-pochinati-likuvannya-preparatom-yuperio-u-paciyentiv-stan-yakih-bulo-stabilizovano-v-likarni 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/chomu-vazhlivij-period-vimivannya-trivalistyu-15-dnya-36-godin-pered-pochatkom-zastosuvannya-yuperio-yaksho-paciyent-uzhe-prijmaye-iapf 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yaki-dozi-yuperio-slid-zastosovuvati-u-paciyentiv-starshogo-viku 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-pochinati-likuvannya-preparatom-yuperio-u-paciyentiv-z-porushennyam-funkciyi-nirok 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-slid-provoditi-likuvannya-paciyenta-v-yakogo-rozvivayetsya-angionevrotichnij-nabryak-pid-chas-zastosuvannya-yuperio 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-slid-provoditi-likuvannya-paciyenta-v-yakogo-rozvivayetsya-arterialna-gipotenziya-pid-chas-zastosuvannya-yuperio 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-slid-provoditi-likuvannya-paciyenta-v-yakogo-rozvivayetsya-porushennya-funkciyi-nirok-pid-chas-zastosuvannya-yuperio 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/patients-safety/which-type 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/dosing/yak-slid-provoditi-likuvannya-paciyenta-v-yakogo-rozvivayetsya-giperkaliyemiya-pid-chas-zastosuvannya-yuperio 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/cardio-metabolic/uperio/yakym-ye-profil-bezpeky-yuperio 2025-09-03T02:52:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/rheumatology/scapho/psoriatic-arthritis/mechanism 2025-09-29T21:22:13+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/tafinlar 2026-03-30T09:43:00+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/tafinlar/application-features 2026-03-30T09:39:10+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/tafinlar/dosing 2026-03-30T09:39:17+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/tafinlar/method-doses 2026-03-28T12:57:48+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/tafinlar/adverse-reactions 2026-03-30T09:39:23+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/mekenist 2026-03-30T09:41:42+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/mekenist/application-features 2026-03-30T09:38:26+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/mekenist/dosing 2026-03-30T07:52:02+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/mekenist/method-doses 2026-03-30T07:54:05+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/medicines/oncology/mekenist/adverse-reactions 2026-03-30T09:38:17+00:00 daily 0.5 https://www.pro.novartis.com/ua-uk/sitemap.xml 2026-04-02T01:10:53+00:00